Asia Leaders
Daphne Koller’s $800 Million AI Bet Is Reaching Its First Human Trial Test
Daphne Koller has financed insitro with roughly $800 million in capital and collaboration revenue. Its first AI-discovered MASH programme is nearing the point where patients, not models, set the valuation.